Poly-energy Cyclic Peptide EAC is a cutting-edge cellular energizing raw material innovatively combining Mellgen's transdermal cyclic peptide delivery system with high-energy bio-actives (including energy adenosine and Artemia extract) to provide continuous metabolic vitality and enhanced cutaneous penetration.
Its bio-actives work synergistically to optimize microcirculation, boost mitochondrial cellular energy turnover, and promote endogenous collagen synthesis. It effectively combats skin sagging, dullness, fine lines, and lack of tone, delivering superior firming, radiance, and structural lifting in luxury face creams and eye contour treatments.
Melanogenesis Inhibition
Nonapeptide-1 competitive binding to MC1R receptor inhibiting tyrosinase pathway.
RAW MATERIAL TECHNICAL & REGULATORY DOSSIER
Comprehensive Technical, Quality Specification, and Regulatory Dossier for R&D Formulators, Procurement, and Product Managers
📊
Biotechnology Mechanism & Scientific Evidence
Authoritative Brochure Technical Diagram · Molecular Model · Transdermal & Efficacy Mechanism
Mechanism DiagramNonapeptide-1 competitive binding to melanocyte MC1R receptor inhibiting tyrosinase pathway.
🔬
Formulation R&D Engineer Guide (R&D Technical Dossier)
Formulation Application · Physicochemical Parameters · Stability & Compatibility
| INCI Name (CN) |
卤虫（ARTEMIA）Extract物、Decapeptide-4、Cyclic AMP、skin 醇、1,2-1,2-Hexanediol, Aqua |
INCI Name (EN) |
Artemia Extract, Decapeptide-4, Adenosine Cyclic Phosphate, Inositol, 1,2-Hexanediol, Aqua |
| CAS No. |
917094-11-2 / 60-92-4 / 87-89-8 / 6920-22-5 / 7732-18-5 |
Recommended Dosage |
0.3% - 3.0%（ Brightening 0.5% - 1.5%） |
| Optimal pH Range |
5.0 - 7.5 |
Thermal Processing |
Extremely heat stable up to 80°C |
| Appearance & Odor |
Clear colorless liquid, odorless |
Solubility & Method |
Freely soluble in water |
💡 Compatibility Guidelines & Precautions: Broad compatibility across diverse pH levels and emulsion matrices
📦
Procurement & Compliance Dossier (Procurement & Compliance)
NMPA Code · MOQ · Sampling Support · Certificate of Analysis
| NMPA Submission Code |
✓ 219365-00075-6463 |
Supply Packaging |
1kg/fluorinated bottle, 5kg/drum, 25kg/drum |
| Minimum Order Quantity (MOQ) |
1 kg (Ready Stock) |
Delivery Lead Time |
Dispatched within 24-48 hours |
| Storage Conditions |
Store in a cool, dark, dry place below 25°C |
Shelf Life (Shelf Life) |
36 Months |
| R&D Sample Support |
Complimentary 30g trial sample available with elasticity test reports |
Quality Documentation |
Batch COA, SDS, TDS, HPLC Purity Certificate |
💡
Product Planning & Marketing Highlights (Marketing Highlights)
Core Mechanism · Efficacy Claims · Recommended Formats · Scientific Backing
🧬 Core Bio-Tech Barrier & Mechanism of Action:
The cyclic closed conformation protects peptide bonds from exopeptidases and endopeptidases, allowing extended receptor interaction to stimulate LOXL-1 and tropoelastin assembly into mature elastic fibers.
✨ Key Selling Point Keywords:
🏷️ Conformationally Stable Closed-Loop Cyclic Peptide🏷️ Superior Enzymatic Resistance & Absorption🏷️ Promoting Elastic Fiber Network Fullness🏷️ Improving Sagging & Laxity🏷️ Elevating Facial Firmness
🧴 Recommended Product Formats & Categories:
Firming bounce serums, jawline contouring essences, anti-gravity tightening creams, eye lifting treatments
📜 Patented Technologies & Scientific Backing:
Granted Chinese and US Invention Patents on Cyclic Peptide Chemical Synthesis & Skin Penetration
⚖️
Regulatory Compliance & Peer-to-Peer Disclaimer
Regulatory & Professional Compliance Statement:
1. The raw material characteristics and experimental data (including cytological studies, mechanism diagrams, and literature citations) presented on this webpage are intended exclusively for technical discussion and formulation R&D reference by cosmetic brand formulators, R&D engineers, product planners, and academic research institutions. They do not constitute finished consumer cosmetic efficacy claims or commercial warranties.
2. Pursuant to the Regulations on the Supervision and Administration of Cosmetics, Standards for Cosmetic Efficacy Claim Evaluation, and relevant global cosmetic regulatory frameworks, cosmetic brand enterprises utilizing this raw material shall be solely responsible for the safety, stability, and efficacy claims of their finished consumer products, and shall independently complete efficacy evaluations and regulatory filings/registrations with the competent health authorities prior to commercial launch. Conclusions from in-vitro or cellular studies shall not be directly extrapolated as consumer claims.
3. Mellgen Biotech assumes no joint or indirect liability for any claims or regulatory non-compliance arising from improper customer formulation, unauthorized off-label claims, or unverified applications.
